DalsnaFinance › IPOs › Curanex Pharmaceuticals › IPO
Curanex Pharmaceuticals Inc completed its initial public offering on NASDAQ on August 26, 2025, pricing at $4.00 a share.
| Ticker | CURX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | August 26, 2025 |
| Offering price | $4.00 |
| Shares offered | 3,750,000 |
| Total raised | $15M |
Curanex Pharmaceuticals Inc sold 3,750,000 shares at $4.00 each on NASDAQ. Multiplied out, that is $15 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $15 million total recorded for the deal.
Measured by money raised, Curanex Pharmaceuticals Inc was tied for the 420th largest (level with 16 other deals) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is tied for the 310th largest (level with 14 other listings).
August 2025 saw 21 completed IPOs in the site's data; by amount raised, Curanex Pharmaceuticals Inc was tied for the 16th largest (level with 3 other deals) of the 21 deals with a recorded size.
Its $4.00 offer price was tied for the 440th highest (level with 37 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Curanex Pharmaceuticals Inc — quote, profile and latest news →
Source: SEC EDGAR filings for Curanex Pharmaceuticals Inc. This page is general information, not investment advice.